{"product_id":"asia-pacific-cell-culture-market-share-size-trends-industry-analysis-report-by-product-by-consumables-plates-flasks-dishes-vials-tubes-bottles-and-others-by-application-by-country-segment-forecast-2018-2030","title":"Asia Pacific Cell Culture Market Share, Size, Trends, Industry Analysis Report, By Product; By Consumables (Plates, Flasks, Dishes, Vials, Tubes, Bottles, and Others); By Application; By Country; Segment Forecast, 2018 - 2030","description":"\u003cp\u003eAsia Pacific Cell Culture Market Share, Size, Trends, Industry Analysis Report, By Product; By Consumables (Plates, Flasks, Dishes, Vials, Tubes, Bottles, and Others); By Application; By Country; Segment Forecast, 2018 - 2030\u003c\/p\u003e\n\n\u003cp\u003eThe asia pacific cell culture market size is expected to reach USD 14,603.90 million by 2030, according to a new study by Polaris Market Research. The report “Asia Pacific Cell Culture Market Share, Size, Trends, Industry Analysis Report, By Product; By Consumables (Plates, Flasks, Dishes, Vials, Tubes, Bottles, and Others); By Application; By Country; Segment Forecast, 2023 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.\u003c\/p\u003e\n\n\u003cp\u003eThe region has witnessed significant growth in the market due to increasing investments in life sciences research, the rising demand for biopharmaceuticals, and advancements in healthcare infrastructure. The focus on research and development activities, collaborations, and advanced research facilities equipped with cell culture technologies have driven market growth. The region's increasing prevalence of chronic diseases, aging population, and need for advanced therapeutics have fueled the demand for cell culture products and techniques, particularly in producing biopharmaceuticals like monoclonal antibodies and vaccines.\u003c\/p\u003e\n\n\u003cp\u003eImprovements in healthcare infrastructure, especially in countries such as China, India, and Japan, have further supported the adoption of cell culture techniques. Investments in healthcare facilities and the expansion of pharmaceutical manufacturing capabilities have created a favorable environment for the growth of the cell culture market. Pharmaceutical companies in the region increasingly rely on cell culture for drug discovery, development, and production.\u003c\/p\u003e\n\n\u003cp\u003eThe COVID-19 pandemic had a moderate impact on the cell culture market in the Asia Pacific region. Disruptions caused by lockdowns, travel restrictions, and supply chain challenges affected research activities and biopharmaceutical production. However, there was an increased demand for cell culture-based testing, vaccine development, and antibody production in response to the pandemic. Overall, the market experienced temporary setbacks and opportunities arising from the need for pandemic-related solutions.\u003c\/p\u003e\n\n\u003cp\u003eAsia Pacific Cell Culture Market Report Highlights\u003c\/p\u003e\n\n\u003cp\u003eCulture Systems emerged as the market leader in 2022, offering high-quality and innovative cell culture products backed by strong distribution and customer support, driving its success in Asia.\u003c\/p\u003e\n\n\u003cp\u003ePlates dominated the market in 2022 with its high-quality, specialized products, meeting the demands of researchers and biotech companies and leveraging a strong distribution network.\u003c\/p\u003e\n\n\u003cp\u003eChina dominated the market by leveraging its growing biopharmaceutical industry, investments in research and development, and expanding the healthcare sector, establishing itself as a key player.\u003c\/p\u003e\n\n\u003cp\u003eThe key market players include Thermo Fisher Scientific, GE Healthcare, Eppendorf AG, Sartorius AG, Lonza AG, Becton, Dickinson and Company, Corning, Promocell GmbH, Hi-Media Laboratories.\u003c\/p\u003e\n\n\u003cp\u003ePolaris Market Research has segmented the Asia Pacific cell culture market report based on product, consumables, application, and country:\u003c\/p\u003e\n\n\u003cp\u003eAsia Pacific Cell Culture, Product Outlook (Revenue - USD Million, 2018 - 2030)\u003c\/p\u003e\n\n\u003cp\u003eCulture Systems\u003c\/p\u003e\n\n\u003cp\u003eIncubators\u003c\/p\u003e\n\n\u003cp\u003eCentrifuges\u003c\/p\u003e\n\n\u003cp\u003eCryostorage Equipment\u003c\/p\u003e\n\n\u003cp\u003eBiosafety Equipment\u003c\/p\u003e\n\n\u003cp\u003ePipetting Instruments\u003c\/p\u003e\n\n\u003cp\u003eAsia Pacific Cell Culture, Consumables Outlook (Revenue - USD Million, 2018 - 2030)\u003c\/p\u003e\n\n\u003cp\u003ePlates\u003c\/p\u003e\n\n\u003cp\u003eFlasks\u003c\/p\u003e\n\n\u003cp\u003eDishes\u003c\/p\u003e\n\n\u003cp\u003eVials\u003c\/p\u003e\n\n\u003cp\u003eTubes\u003c\/p\u003e\n\n\u003cp\u003eBottles\u003c\/p\u003e\n\n\u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eAsia Pacific Cell Culture, Application Outlook (Revenue - USD Million, 2018 - 2030)\u003c\/p\u003e\n\n\u003cp\u003eBiopharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003eTissue Culture \u0026amp; Engineering\u003c\/p\u003e\n\n\u003cp\u003eVaccine Production\u003c\/p\u003e\n\n\u003cp\u003eDrug Development\u003c\/p\u003e\n\n\u003cp\u003eGene Therapy\u003c\/p\u003e\n\n\u003cp\u003eToxicity Testing\u003c\/p\u003e\n\n\u003cp\u003eCancer Research\u003c\/p\u003e\n\n\u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eAsia Pacific Cell Culture, Country Outlook (Revenue - USD Million, 2018 - 2030)\u003c\/p\u003e\n\n\u003cp\u003eJapan\u003c\/p\u003e\n\n\u003cp\u003eChina\u003c\/p\u003e\n\n\u003cp\u003eIndia\u003c\/p\u003e\n\n\u003cp\u003eSouth Korea\u003c\/p\u003e\n\n\u003cp\u003eAustralia\u003c\/p\u003e\n\n\u003cp\u003eNew Zealand\u003c\/p\u003e\n\n\u003cp\u003eRest of Asia Pacific\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"July, 2023 \/ 115 Pages \/ MCW16231350","offer_id":47647292162354,"sku":null,"price":5100.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/asia-pacific-cell-culture-market-share-size-trends-industry-analysis-report-by-product-by-consumables-plates-flasks-dishes-vials-tubes-bottles-and-others-by-application-by-country-segment-forecast-2018-2030","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}